ASYMMETRIC SYNTHESIS OF BIOACTIVE ALKALOIDS
生物活性生物碱的不对称合成
基本信息
- 批准号:3295495
- 负责人:
- 金额:$ 10.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1987
- 资助国家:美国
- 起止时间:1987-07-01 至 1990-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The objective of this proposal is to develop a new synthetic
approach to the naphthyridinomycin and quinocarcin families of
isoquinoline alkaloids. Since these substances inhibit DNA
synthesis they are potential antineoplastic agents. Methodology
will be explored that allows for the stereoselective assembly of
these structurally complex targets from chiral, nonracemic
precursors. Thus asymmetric syntheses of the requisite
phenylglycinol derivatives will be investigated first. These
starting materials will be incorporated into a scheme that relies
on a novel 1,3-dipolar cycloaddition reaction to construct the 3,8-
diazabicyclo(3.2.1)octane moiety common to both target families.
In this context, complimentary photochemical and thermal routes
to azomethine ylides will be explored. The latter method would
involve a novel valence tautomerization of enamines for ylide
generation. Both inter- and intramolecular variations of this key
addition will be investigated in detail, with complete
stereocontrol as a goal. Subsequent Hoesch cyclization
(isoquinoline formation) sets the stage for the final sequence of
events that should lead to the desired targets and analogues
thereof.
As mentioned above, these target substances have been shown to
inhibit DNA synthesis and (at least for naphthyridinomycin) this
seems to occur as a result of irreversible binding to the
deoxyguanidylic acid - deoxycytidylic acid base pairs. A logical
extension of the proposed synthetic work would be an
investigation into the exact nature of this binding to DNA and the
chemical events (ie. activation of the antibiotic) that precede it.
Such studies would be useful for the rational design of new
antineoplastic agents with minimal unwanted side effects. More
importantly perhaps, work of this nature could lead to a better
understanding (and thus control) of DNA synthesis at the cellular
level and the medical problems associated with the malfunction of
this process.
这项建议的目的是开发一种新的合成物
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PHILIP P GARNER其他文献
PHILIP P GARNER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PHILIP P GARNER', 18)}}的其他基金
相似海外基金
The analysis of proteinuria caused by antineoplastics and the preventative effects with antihypertensive medications using the Japanese medical database
利用日本医学数据库分析抗肿瘤药物引起的蛋白尿及抗高血压药物的预防效果
- 批准号:
21K17258 - 财政年份:2021
- 资助金额:
$ 10.11万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Expediting Drug Development by Profiling Novel Antineoplastics by Mass Spectrometry-based Biomarker Profiling
通过基于质谱的生物标志物分析来分析新型抗肿瘤药物,加速药物开发
- 批准号:
499958-2016 - 财政年份:2016
- 资助金额:
$ 10.11万 - 项目类别:
Engage Grants Program
Combinatorial Peptidomimetics as Antineoplastics
作为抗肿瘤药的组合肽模拟物
- 批准号:
6623455 - 财政年份:2002
- 资助金额:
$ 10.11万 - 项目类别:
Combinatorial Peptidomimetics as Antineoplastics
作为抗肿瘤药的组合肽模拟物
- 批准号:
6465958 - 财政年份:2002
- 资助金额:
$ 10.11万 - 项目类别:
Novel Nanoparticle Delivery System for Antineoplastics
新型抗肿瘤纳米颗粒输送系统
- 批准号:
6483914 - 财政年份:2002
- 资助金额:
$ 10.11万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
6124630 - 财政年份:1998
- 资助金额:
$ 10.11万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
6329037 - 财政年份:1998
- 资助金额:
$ 10.11万 - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
2747737 - 财政年份:1998
- 资助金额:
$ 10.11万 - 项目类别:
POLYMORPHIC METABOLISM OF ANTINEOPLASTICS IN CHILDREN
儿童抗肿瘤药物的多态性代谢
- 批准号:
3459680 - 财政年份:1990
- 资助金额:
$ 10.11万 - 项目类别:
POLYMORPHIC METABOLISM OF ANTINEOPLASTICS IN CHILDREN
儿童抗肿瘤药物的多态性代谢
- 批准号:
3459678 - 财政年份:1990
- 资助金额:
$ 10.11万 - 项目类别:














{{item.name}}会员




